10 Calif. hospitals slapped with $700K in fines for medical mistakes

Ten hospitals in California were hit with administrative penalties totaling $700,000 due to medical errors.

The California Department of Public Health (CDPH) issued fines of $50,000 to $100,000 after it found that the facilities’ noncompliance with licensing requirements caused, or was likely to cause, serious injury or death to patients.

Under a state provision, an administrative penalty carries a fine of $50,000 for the first violation, $75,000 for the second and $100,000 for the third or subsequent violation by the facility.

The ten hospitals and fines are:

1. Beverly Hospital: $50,000 for failure to follow policies and procedures regarding the treatment and care of a patient.

2. John F. Kennedy Memorial Hospital: $100,000 for failure to follow policies and procedures regarding the treatment and care of a patient.

3. Kaiser Foundation Hospital – Woodland Hills: $50,000 for failure to follow policies and procedures for safe distribution and administration of medication.

4. Loma Linda University Medical Center: $50,000 for failure to follow policies and procedures regarding the treatment and care of a patient.

5. Mark Twain Medical Center: $50,000 for failure to follow surgical policies and procedures.

6. Palomar Medical Center: $50,000 for failure to follow established policies and procedures regarding the treatment and care of a patient.

7. Rideout Memorial Hospital: $50,000 for failure to follow policies and procedures for safe distribution and administration of medication.

8. Southwest Healthcare: $100,000 for failure to follow policies and procedures regarding the treatment and care of a patient.

9. UCSF Medical Center: $100,000 for failure to follow policies and procedures for safe distribution and administration of medication.

10. University of California, San Diego Medical Center: $100,000 for failure to follow established policies and procedures regarding the safety of a patient.

Facilities are required to provide CDPH with a plan of correction to prevent future incidents, but they can appeal the fine. If a hearing is requested and the penalty upheld following an appeal, the penalties must be paid.

CDPH list

 

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.